SmithKline Beecham U.K. consolidation
Executive Summary
Firm will move its pharmaceutical production from its Welwyn Garden City, Hertfordshire facility to its plant in Crawley, Sussex over an 18-24 month period. However, Welwyn Garden City will serve as the new headquarters of SmithKline Beecham Pharmaceuticals' U.K. operation, beginning in March. Also, the company says it plans to consolidate all pharmaceutical distribution activities at its Ridgeway site in Welwyn Garden City. The move is expected to be completed by mid-1990. A total of 344 positions will be eliminated over two years.